Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI‐liraglutide study 5)

AIM: Use of the glucagon‐like peptide 1 receptor agonist liraglutide has been shown to reduce weight. Different types of anthropometric measurements can be used to measure adiposity. This study evaluated the effect of liraglutide on sagittal abdominal diameter, waist circumference, waist‐to‐hip rati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadi, S. S., Filipsson, K., Dimenäs, H., Isaksson, S. S., Imberg, H., Sjöberg, S., Ahrén, B., Dahlqvist, S., Gustafsson, T., Tuomilehto, J., Hirsch, I. B., Lind, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469338/
https://www.ncbi.nlm.nih.gov/pubmed/31019730
http://dx.doi.org/10.1002/osp4.324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469338/
https://www.ncbi.nlm.nih.gov/pubmed/31019730
http://dx.doi.org/10.1002/osp4.324

Ejemplares similares